Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
BMJ Open Diabetes Research & Care|October 22, 2020
Impact of tissue macrophage proliferation on peripheral and systemic insulin resistance in obese mice with diabetesYutaro Morita, Takafumi Senokuchi, Sarie Yamada, et al.Journal of Diabetes Investigation|July 7, 2018
Impacts of the 2016 Kumamoto Earthquake on glycemic control in patients with diabetesTatsuya Kondo, Nobukazu Miyakawa, Hiroyuki Motoshima, et al.Biochemical and Biophysical Research Communications|January 16, 2013
Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophagesHiroyuki Kinoshita, Takeshi Matsumura, Norio Ishii, et al.Atherosclerosis|May 27, 2006
Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2Miyuki Yano, Takeshi Matsumura, Takafumi Senokuchi, et al.Endocrine Journal|November 14, 2014
Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapySeiya Shimoda, Mina Okubo, Kotaro Koga, et al.Atherosclerosis|December 20, 2024
Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophagesToshiaki Wada, Takafumi Senokuchi, Yudan Shi, et al.Journal of Clinical Biochemistry and Nutrition|November 30, 2016
Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay miceSatoko Hanatani, Hiroyuki Motoshima, Yuki Takaki, et al.Endocrine Journal|July 17, 2019
Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled studySeiya Shimoda, Wakana Sakamoto, Ayaka Hokamura, et al.The Journal of Biological Chemistry|January 23, 2008
Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophagesKayo Taketa, Takeshi Matsumura, Miyuki Yano, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 29, 2010
Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient miceNorio Ishii, Takeshi Matsumura, Hiroyuki Kinoshita, et al.Pageof 4